Sandra Geraci

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

Francesco Pantano, Martine Croset, Keltouma Driouch et al. · Oncogene · 2021 · 97 citations · Full text

Cancer Research, Sclerostin, Breast Oncology +15

Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study

Sandra Boccard, Sandie V. Marand, Sandra Geraci et al. · Oncotarget · 2015 · 39 citations · Full text

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

Geoffrey Vargas, Mathilde Bouchet, Lamia Bouazza et al. · Oncogene · 2018 · 36 citations · Full text

Primary Breast Tumors, Breast Oncology, Medicine +9

ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response

Mathilde Bouchet, Alexandra Lainé, Cyril Boyault et al. · Cancer Research · 2020 · 30 citations · Full text

Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation

Cédric Boudot, Lucie Hénaut, Ursula Thiem et al. · Oncotarget · 2017 · 25 citations · Full text